PharmaBlock R&D Co. Ltd. was founded at the end of 2006 and became operational in October of 2008 with an initial investment of USD 5.65 million. It is located in the Hi-Tech Zone of Nanjing, a city with 53 universities and colleges, and is 180 miles west of Shanghai. As a chemistry based, research and innovation-driven high-tech company, PharmaBlock provides customers with innovative chemistry services including a catalog of specially designed scaffolds and building blocks; custom synthesis based on in-house products and expertise; process development and large-scale synthesis of key intermediates and APIs. PharmaBlock currently has over 250 people, 140 of those are research scientists. Over 90% employees have bachelor’s degrees or above, 12 are PhDs including 7 oversea returnees with prestigious academic and industrial experiences.

The founders of PharmaBlock, Dr. Minmin Yang, Dr Xihan Wu, and Dr. Shuhai Zhao have previously worked for multinational companies with managerial roles in the field of drug R&D. With extensive experience in medicinal chemistry, molecular modeling and synthetic chemistry, PharmaBlock has designed a special catalog of 20,000 scaffolds & building blocks based on structure information of market drugs, clinical and preclinical candidates. Many of our catalog compounds were not commercially available and over 3,000 of them were not even reported. Those unique and biased structures can help customers quickly explore and establish SARs (structure-activity relationships) for their discovery projects thus maximize the discovery efficiency in making next generation medicines. A series of SAR kit compounds and sets of fragment libraries have also derived from this unique catalog. With chemistry technology and expertise accumulated in synthesizing those catalog compounds, our business has expanded into custom synthesis, process development and manufacture of key intermediates/APIs with challenging chemistry. Our company has been certified by ISO9001, ISO14001 and OHSAS18001 in 2011.

To provide more efficient and timely services to US and European customers, PharmaBlock opened a new facility in San Francisco Bay area in 2011.


 

Talents
— “A Thousand Talent Program” sponsored by the CPC Central Committee's Organization Department: 1
—“Innovative and Entrepreneurial Talents of Jiangsu Province”: 3
—“The Cultivation Program for High-Tech Entrepreneurs” in Nanjing and Jiangsu province: 1
—“Nanjing Zijin Talent Recruitment Program”: 1
— “Innovative and Entrepreneurial Talents of Nanjing High-tech Zone”: 1
—“Top Ten Leading Entrepreneurs” by the Chinese Entrepreneur Park for Oversea Scholars: 1
—“Top Six Peak Talents” of Jiangsu Province: 1
—“Zijin Distinguished High-Tech Entrepreneurs” by Nanjing city: 1
Intellectual property
—25 PCT/CN patent applications filed with 13 granted at the moment
Honors
—2011, “Top 100 fast developing enterprises in Chinese Entrepreneur Parks for Overseas Scholars”
—2011, “Distinguished High-Tech Servicing Enterprise of Nanjing”
—2012, “National Research Center for Postdoctoral Scholars”
—2014, “High-tech Enterprises”
—2014, Recognition by the Enterprise Technology Center of Nanjing